Asianet NewsableAsianet Newsable

WHO accepts Bharat Biotech's Covaxin for emergency use listing

Covaxin has shown 77.8 percent efficacy against symptomatic Covid-19 and 65.2% protection against the novel Delta variant.

World Health Organisation accepts Bharat Biotech's Covaxin for emergency use gcw
Author
New Delhi, First Published Nov 3, 2021, 5:35 PM IST
  • Facebook
  • Twitter
  • Whatsapp

The World Health Organisation has accepted Bharat Biotech's Covaxin for emergency usage on Wednesday. The health body panel had previously requested for more answers from the Hyderabad-based corporation. The Technical Advisory Group convened on October 26 and requested further information from Bharat Biotech. Covaxin has shown 77.8 percent efficacy against symptomatic Covid-19 and 65.2% protection against the novel Delta variant. The business announced in June that it has completed the final study of Covaxin effectiveness from Phase 3 studies.

Union Health Minister Mansukh Mandaviya hailed it a "victory for Atmanirbhar Bharat" and praised Prime Minister Narendra Modi's "goodwill and dedication."

Also Read | WHO seeks ‘additional clarifications’ from Bharat Biotech to approve Covaxin

Earlier in the day, Bharat Biotech announced in a press release that the Central Drugs Standard Control Organization has approved extending Covaxin's shelf-life to 12 months from the date of manufacture. This shelf-life extension permission was given based on the submission of new stability data to CDSCO.

Covaxin is one of three COVID-19 vaccines now being deployed in the country as part of a huge statewide immunisation campaign. The other two are Covishield from the Serum Institute of India and Sputnik V from Russia. Until date, the World Health Organization has authorised COVID-19 vaccines made by Pfizer-BioNTech, Johnson & Johnson, Moderna, Sinopharm, and Oxford-AstraZeneca for emergency use.

Also Read | Bharat Biotech’s COVID-19 vaccine Covaxin gets shelf life extension to 12 months

Meanwhile, during a meeting on the margins of the G20 conference in Geneva last week, Prime Minister Narendra Modi pushed WHO director Tedros Adhanom Ghebreyesus to expedite the nod.Mea

Follow Us:
Download App:
  • android
  • ios